InterCure Ltd. (INCR) vs Rockwell Medical, Inc. (RMTI)
- InterCure Ltd. INCR 4.66 +0.22%
- Rockwell Medical, Inc. RMTI 7.43 −6.89%
InterCure Ltd. and Rockwell Medical, Inc. are both Drug Manufacturers Specialty & Generic companies. InterCure Ltd. is the larger, with a market value of $55.1M against $32.2M — 1.7× the size. Rockwell Medical, Inc. has negative trailing earnings, so its P/E is not meaningful; InterCure Ltd. trades at 8.8×. InterCure Ltd. grew revenue faster over the last twelve months: 16.2% against −21.1%. InterCure Ltd. has the higher net margin (4.88% vs −7.33%) and the higher return on invested capital (0.00% vs −14.6%). Across the 18 metrics below, InterCure Ltd. leads on 14 and Rockwell Medical, Inc. on 4.
Valuation
Profitability
| Metric | INCR | RMTI | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 32.74% | 17.71% | 53.94% |
| Operating margin | 0.00% | (6.52%) | 0.00% |
| Net margin | 4.88% | (7.33%) | 0.00% |
| Free cash flow margin | 0.00% | 2.47% | 0.00% |
| Return on equity | 0.00% | (15.53%) | (0.40%) |
| Return on assets | 0.00% | (9.32%) | (3.32%) |
| Return on invested capital | 0.00% | (14.58%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack